Drug manufacturer agrees to $500 million penalty
Monday, May 13, 2013
Text Size: A | A
WASHINGTON — A subsidiary of an Indian pharmaceutical company has agreed to pay $500 million fines and civil penalties for selling adulterated drugs and lying about tests to federal regulators, the Justice Department said Monday. ..